Latest News and Press Releases

HUDDINGE, Sweden, June 3, 2004 (PRIMEZONE) -- The final count for Medivir's new share issue shows that 4,263,695 B shares, corresponding to 99.16 percent of those offered, were subscribed through the...

HUDDINGE, Sweden, May 28, 2004 (PRIMEZONE) -- Following the close of the subscription period for Medivir's new share issue for SEK 322.5m, preliminary figures indicate subscription for slightly more...

HUDDINGE, Sweden, May 13, 2004 (PRIMEZONE) -- Bo Oberg, Nils-Gunnar Johansson and certain of their colleagues at Medivir have sold a total of 1,062,285 subscription rights to Handelsbanken Capital...

HUDDINGE, Sweden, April 22, 2004 (PRIMEZONE) -- The Board of Medivir AB decided on 15 March 2004 to conduct a new share issue of approximately SEK 322m. The decision is conditional on approval by the...

HUDDINGE, Sweden, March 31, 2004 (PRIMEZONE) -- The European Patent Office today granted a patent on Medivir's herpes project ME-609. Medivir currently has operational responsibility for development...

HUDDINGE, Sweden, March 30, 2004 (PRIMEZONE) -- At the Microbicides 2004 International Congress in London, Medivir and The Population Council presented preclinical results from a combination of...

HUDDINGE, Sweden, March 29, 2004 (PRIMEZONE) -- Medivir and Peptimmune jointly announce today that an orally active, small molecule inhibitor of the protease enzyme Cathepsin S has been selected as a...

HUDDINGE, Sweden, March 16, 2004 (PRIMEZONE) -- Medivir: - Major progress has recently been made in two of Medivir's late pre-clinical projects, Cathepsin S (inflammatory diseases) and Cathepsin K...

HUDDINGE, Sweden, Feb. 17, 2004 (PRIMEZONE) -- -- MIV-310 was outlicensed to Boehringer Ingelheim in July in a global licensing agreement with a total contract value of Eur 122 m. -- MIV-210 was...

HUDDINGE, Sweden, Dec. 05, 2003 (PRIMEZONE) -- GlaxoSmithKline (GSK) and Medivir entered a licensing agreement for MIV- 210 a nucleoside analogue reverse transcriptase inhibitor (NRTI), in May 2003....